keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Trofinetide (NNZ-2566) 是一种内源性 N 末端三肽甘氨酸-脯氨酸-谷氨酸 (GPE) 的合成类似物,在脑损伤的动物模型中显示出神经保护作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 888 | 现货 | ||
5 mg | ¥ 2,720 | 现货 | ||
10 mg | ¥ 3,970 | 现货 | ||
25 mg | ¥ 6,490 | 现货 | ||
50 mg | ¥ 8,860 | 现货 | ||
100 mg | ¥ 11,900 | 现货 |
产品描述 | Trofinetide (NNZ-2566) is a synthetic analog of the endogenous N-terminus tripeptide. It has been shown to be neuroprotective in animal models of brain injury. |
体内活性 | Trofinetide treatment suppresses IL-1β expression in the injured brain hemisphere for up to 7 days post-PBBI. Trofinetide suppresses penetrating ballistic-like brain injury-induced inflammatory cell infiltration at 3 days following PBBI as compared to vehicle treatment. All doses of Trofinetide completely suppress the delayed occurrence of NCS as compare with the vehicle-treated animals. Trofinetide treatment produces significant reductions in the injury-induced up-regulation of IL-1β, INF-γ, and TNF-α expression. Trofinetide treatment significantly decreases the elevation of IL-6 (79%), E-selectin (81%), IL-1β (76%), and TNF-α (72%) mRNA levels in the injured hemisphere at 12 h post-PBBI, with maximal inhibition occurring between 12 h and 24 h. The high doses of Trofinetide (10 and 100 mg/kg bolus followed by continuous infusion) attenuate non-convulsive seizure (NCS) occurring beyond 2 h after permanent middle cerebral artery occlusion [1][2]. |
别名 | NNZ-2566 |
分子量 | 315.32 |
分子式 | C13H21N3O6 |
CAS No. | 853400-76-7 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 44 mg/mL (139.54 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 3.1714 mL | 15.8569 mL | 31.7138 mL | 79.2845 mL |
5 mM | 0.6343 mL | 3.1714 mL | 6.3428 mL | 15.8569 mL | |
10 mM | 0.3171 mL | 1.5857 mL | 3.1714 mL | 7.9285 mL | |
20 mM | 0.1586 mL | 0.7928 mL | 1.5857 mL | 3.9642 mL | |
50 mM | 0.0634 mL | 0.3171 mL | 0.6343 mL | 1.5857 mL | |
100 mM | 0.0317 mL | 0.1586 mL | 0.3171 mL | 0.7928 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Trofinetide 853400-76-7 Others NNZ-2566 NNZ2566 NNZ 2566 Inhibitor inhibit inhibitor